The Role of Interleukin-6 Inhibitors in the Treatment of COVID-19 Infections: A Case Series

An outbreak of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) infection started in December 2019 in China that resulted in a global health emergency. The World Health Organization later named the disease as coronavirus disease 2019 (COVID-19). Currently, there is no effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Tadepalli, Satish, Vanjarapu, Jagan Mohan Rao, De Dona, Anna, Cheriyath, Pramil, Nookala, Vinod
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364429/
https://www.ncbi.nlm.nih.gov/pubmed/32685300
http://dx.doi.org/10.7759/cureus.8631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364429/
https://www.ncbi.nlm.nih.gov/pubmed/32685300
http://dx.doi.org/10.7759/cureus.8631

Ejemplares similares